Envista Lifts 2026 EPS Target to $1.55-Can 5% Q2 Growth Turn a Turnaround Story Into a Real Buy?

Envista's raised outlook changes the stock's near-term test

The new target raises the bar

The narrative has changed. After a good start in Q1 and another solid quarter, management said it raised its full year outlook, lifting adjusted EPS to $1.50-$1.55 from $1.35 to $1.45. The company also raised its core sales growth target to 3.5%-4.5% from 2%-4%. Once a company raises the scoreboard, investors stop paying for potential and start paying for delivery.

The opportunity is still there. Envista posted 9.5% core revenue growth in Q1 and 5.0% core sales growth in Q2, while adjusted EBITDA margin reached 14.7%. That makes the higher earnings target look more earned than cosmetic. The risk is also higher now: if execution slips, the stock has less room for error than it did when the bar was lower.

Q2 looks stronger because growth and margin expansion broadened

Growth is not coming only from cost discipline

In Q2, Envista produced $731 million in sales with 5.0% core sales growth. Adjusted EBITDA rose to $108 million and adjusted EBITDA margin expanded to 14.7%, up 230 basis points year over year. That raises the key question: was profit growth driven mainly by cost cuts, or by a stronger business?

The evidence points to both, with the underlying business doing more of the heavy lifting. Management said both segments grew and that gains came across all major geographies. That matters because broad-based growth usually suggests the market is absorbing more product, not just watching a company wring out waste. A turnaround driven mostly by trimming costs can work for a while, but it usually hits a ceiling sooner.

Q1 makes Q2 easier to believe in

Q2 alone was encouraging. Q1 makes it harder to dismiss as a one-off. Earlier this year, Envista posted 9.5% core revenue growth, and that top-line momentum converted into 25% adjusted EBITDA growth and 50% EPS growth. Just as important, the company said it still funded double-digit increases in R&D and Sales & Marketing investment.

That is a useful distinction. If management hits numbers by cutting spending, investors should stay cautious. If it expands profit while still investing behind growth, that usually points to stronger demand, better mix, or some combination of the two.

Brand reach gives the turnaround more room to work

Envista says it has more than 30 trusted brands. Its products are found in 90% of dentists' offices, and more than 1 million professional partners rely on its technology daily. That does not guarantee execution, but it does suggest a broad customer base and a franchise with repeat-purchase potential.

For investors, that breadth matters. A wide dental franchise can turn one strong quarter into a pattern because supplies, instruments, and workflows often create repeat orders over time. The main watchpoint is straightforward: if future quarters keep showing growth across categories while margins hold, the story looks more durable.

The upside case is clearer, but the stock still needs follow-through

Why the stock can still rerate

The bull case is simple: if Envista keeps turning moderate sales growth into profit, the market can start paying for more than a fix-it story. Q1 showed the lever, with 9.5% core revenue growth driving much faster EBITDA and EPS growth. Q2 showed the pattern was not a flash, as 5.0% core sales growth came with another round of margin expansion to 14.7% adjusted EBITDA margin.

If that conversion holds in the second half, Envista has a credible path to its new outlook. Markets often rerate a company before the final number arrives, once investors start to believe management can defend a higher bar rather than simply clear a low one.

The trap: any softness in H2 could make the new target look tight

The bear case is not that Envista lacks merit. It is that the stock now needs clean execution, not just better-than-feared quarters. Management has already moved from 2% to 4% core sales growth and adjusted earnings of $1.35 to $1.45 per share to a new adjusted EPS target of $1.50-$1.55. That is the risk: what looks like progress in one quarter can look fragile in the next if growth slows and the company has to defend a higher target.

If the second half softens, the issue will not be that the franchise is broken. It will be that 5.0% core sales growth was strong enough to lift sentiment, but not strong enough to make the new EPS range feel easy.

What to watch next

The next few quarters will determine whether Envista is becoming a genuine buy on improving fundamentals or just a turnaround the market is funding too early.

• Consistency across segments and regions: Management has already said both segments and major geographies grew. Investors should watch whether that breadth continues.
• Margin durability: A 14.7% adjusted EBITDA margin is solid, but the key question is whether Envista can hold or improve it without leaning too heavily on cost actions.
• Investment behind growth: If the company keeps funding R&D and sales support while expanding profit, that would support the case that demand, not just discipline, is driving the story.

The central question is no longer whether Envista can recover. It is whether recovery is becoming steady enough to support a higher valuation.